- ►diabetesjournals.org JL Gross, MJ de Azevedo, SP Silveiro, LH … - Diabetes Care, 2005 - Am Diabetes Assoc Diabetic nephropathy is the leading cause of kidney disease in patients starting
renal replacement therapy and affects ∼40% of type 1 and type 2 diabetic
patients. It increases the risk of death, mainly from cardiovascular ... Cited by 214 - Related articles - All 18 versions
F Bacha, R Saad, N Gungor, SA Arslanian - Diabetes care, 2004 - Am Diabetes Assoc RESULTS—Obese adolescents had ∼50% lower adiponectin than normal-weight
adolescents. Moreover, obese adolescents with high (111.8 ± 9.3 cm 2 ) versus
low (55.4 ± 2.1 cm 2 ) VAT had lower adiponectin levels (6.2 ± 0.9 vs. ... Cited by 141 - Related articles - BL Direct - All 7 versions
K ROSSING, KJ SCHJOEDT, BR JENSEN, F … - Kidney international, 2005 - nature.com This double-masked randomized crossover trial included 52 (41 males)
hypertensive type 2 diabetic patients with microalbuminuria on ongoing
antihypertensive medication. At inclusion, previous antihypertensive ... Cited by 129 - Related articles - BL Direct - All 3 versions
- ►adisonline.com [PDF] KF Croom, MP Curran, KL Goa, CM Perry - Drugs, 2004 - ingentaconnect.com 0012-6667/04/0009-0999/$34.00/0 2004 Adis Data Information BV. All rights
reserved. ... A Review of its Use in Hypertension and in the Management of
Diabetic Nephropathy ... Katherine F. Croom, Monique P. Curran, Karen L. ... Cited by 48 - Related articles - BL Direct - All 6 versions
E Ritz - The American journal of medicine, 2006 - Elsevier The importance of renal function as both a marker of and risk factor for
cardiovascular disease is increasingly recognized. This link is apparent even in
the earliest stages of renal dysfunction, at levels that are conventionally ... Cited by 31 - Related articles - All 10 versions
- ►asnjournals.org ML Caramori, P Fioretto, M Mauer - Journal of the American Society of Nephrology, 2006 - Am Soc Nephrol Diabetic nephropathy (DN) is a growing cause of ESRD despite widely known
recommendations for improved glycemic and BP control. Perhaps earlier
identification of patients who have diabetes and are at high risk for DN ... Cited by 30 - Related articles - BL Direct - All 5 versions
- ►adisonline.com [PDF] PA Meredith - American Journal of Cardiovascular Drugs, 2005 - ingentaconnect.com Angiotensin II receptor antagonists (angiotensin receptor blockers; ARBs) and
thiazide diuretics have an Abstract accepted place in the management of
hypertension. Most patients require combination therapy with two or more ... Cited by 24 - Related articles - All 7 versions
M Volpe - International journal of clinical practice, 2008 - medscape.com This paper provides a comprehensive review of the published literature
pertaining to links between microalbuminuria, hypertension and CV disease, a
discussion of the use of microalbuminuria as a sensitive early predictor of ... Cited by 9 - Related articles - BL Direct - All 6 versions
RV Milani - Am J Manag Care, 2005 - hcplive.com The control of hypertension in the United States remains suboptimal despite a
high degree of awareness of the disease. The most recent analysis of the
National Health and Nutrition Examination Survey (NHANES) in 1999-2000 ... Cited by 9 - Related articles - View as HTML - All 6 versions
F de Alvaro, O Velasco, J Honorato, C Calvo, … - Kidney International-Supplements, 2005 - nefrologia.sk Kidney International, Vol. 67, Supplement 93 (2005), pp. S29–S34 ... FERNANDO
DE ´ALVARO, OLGA VELASCO, JES ´US HONORATO, CARLOS CALVO, INMA PARRONDO, ON
BEHALF OF KORAL HT INVESTIGATORS ... Hospital Universitario La Paz, ... Cited by 7 - Related articles - All 4 versions
